Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Carlos Caldas
Based on 147 articles published since 2009
(Why 147 articles?)
||||
Expertise Level
The expertise of Carlos Caldas ranks in the
  • Top 0.059%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 147 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Caldas, Carlos   ·   Caldas, C
Work Locations
Details
Most likely:    University of Cambridge      
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, 94305, CA, USA. · Department of Pathology, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Department of Biology, Stanford University, Stanford, 94305, CA, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Maimonides Medical Center, Brooklyn, 11219, NY, USA. · Norris Comprehensive Cancer Center, Los Angeles, 90033, CA, USA. · Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. · Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 90333, CA, USA. · Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA. · Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Pubmed 30737380
  • Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, United Kingdom. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden. · Department of Pathology, Academic Medical Center, 1105AZ Amsterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Département de Biopathologie, Institut Bergonié, CS 61283 33076 Bordeaux, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium. · Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium. · Molecular Immunology Unit, Jules Bordet Institute, B-1000 Brussels, Belgium. · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Department of Radiation Oncology, and Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, 4029 Brisbane, Australia. · Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium. · Istituto Tumori G Paolo II, IRCCS, 70124 Bari, Italy. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. · Institut Curie, Department of Pathology and INSERM U934, 75248 Paris Cedex 05, France. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 38330 Montbonnot-Saint Martin, France. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radiumhospital, 0310 Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, 0310 Oslo, Norway. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands. · Pubmed 30692147
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 30520388
2018
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
  • The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Academic Urology Group, Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Institute of Molecular Biology (IMB), Mainz, Germany. · Department of Biochemistry, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Hinxton, UK. · AstraZeneca, Waltham, MA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · AstraZeneca, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Pubmed 30022119
  • Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. · Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford, CA 94305, USA. · Stanford Cancer Institute, Stanford, CA 94305, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Breast Cancer Program, CRUK Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA; California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA; San Francisco Veterans Affairs Medical Center, San Francisco, San Francisco, CA 94121, USA. · Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. Electronic address: · Pubmed 29731168
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. · The Smoler Protein Center, Department of Biology, Technion, Haifa 32000, Israel. · Cancer Research UK Cambridge Institute and the Cambridge Cancer Centre, Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. · Department of Immunology and Cancer Research and Department Pathology, Hebrew University-Hadassah Medical School, Jerusalem 91010, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 29382783
  • CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Novocraft Technologies Sdn Bhd, C-23A-05, 3 Two Square, Jalan 19/1, Section 19, 46300, Petaling Jaya, Selangor Darul Ehsan, Malaysia. · CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Pubmed 29304755
2017
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Pathology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Computer Science, University of Oslo, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Medicine, University of Oslo, Oslo, Norway. · Department of Oncology, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. Electronic address: · Pubmed 28733194
  • Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. · Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. Electronic address: · Pubmed 28694015
  • Li Ka Shing Centre, Cancer Research UK Cambridge Institute. · Department of Pathology. · Institute of Astronomy, University of Cambridge, Cambridge. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 28525534
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy & Developmental Biology, Monash University, Clayton, VIC, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Research and Development, Lincoln Breast Unit, Lincoln County Hospital, Lincoln, UK. · Nottingham Digestive Disease Centre, Faculty of Medicine and Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. · PathLinks, Lincoln County Hospital, Lincoln, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 28697743
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Department of Pathology, College of Medicine, Al Mustansiriyah University, Baghdad, Iraq. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Pubmed 28478613
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway. · Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. · Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Five3 Genomics, LLC, Santa Cruz, CA, 95060, USA. · Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Surgery, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. · Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway. · Department of Pathology, Akershus University Hospital, Lørenskog, Norway. · Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 28356166
  • Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 27648723
  • 1 MRC Biostatistics Unit, Cambridge, UK. · 2 Cancer Research UK Cambridge Institute, Cambridge, UK. · 3 Department of Pathology, University of Cambridge, Cambridge, UK. · 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · 5 Department of Oncology, University of Cambridge, Cambridge, UK. · 6 NIH Cambridge Biomedical Research Centre, Cambridge, UK. · 7 Strangeways Research Laboratory, Cambridge, UK. · Pubmed 25193065
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Pubmed 26776681
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, United Kingdom. · Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, Leeds, United Kingdom. · Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. · Pubmed 27392074
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 27542606
  • Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, South Australia, Australia. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Breast Cancer Genomics Group, Cancer Research UK, Cambridge Institute, Cambridge University, Cambridge, United Kingdom. · Nuclear Transcription Factor Laboratory, Cancer Research UK, Cambridge Institute, Cambridge University, Cambridge, United Kingdom. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 27496708
  • Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. · Cancer Research UK, Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · CCR Collaborative Bioinformatics Resource, Advanced Biomedical Computing Center, Leidos Biomed, Frederick National Laboratory, Frederick, MD, USA. · Breakthrough Breast Cancer Unit, Institute of Cancer Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK. · Pubmed 27181204
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, United Kingdom. · Department of Breast and Endocrine Surgery, Akershus University Hospital, Lorenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Department of Informatics, University of Oslo, Oslo, Norway. · Institute of Cancer Genetics and Informatics, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Pubmed 27082076
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. · Cellular Pathology, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK. · Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE. · Pubmed 26954716
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Present address: Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, UK. · Royal Bournemouth Hospital and Bournemouth University, Castle Lane East, Bournemouth, UK. · Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, Peterborough, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Pubmed 26882907
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Department of Pathology and Oncology, Medical Faculty of the University of Porto, Porto, Portugal Centro Hospitalar São João, Porto, Portugal. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, University of Cambridge, Cambridge, UK. · No Stomach For Cancer, Inc., Madison, Wisconsin, USA. · Department of Oesophago-Gastric Surgery, Addenbrooke's Hospital, Cambridge, UK. · Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgical Gastroenterology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands. · Vinery Lane Surgery, Whangarei, New Zealand. · Division of Psychosocial Research and Epidemiology/Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Gastroenterology and Hepatology, Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · The DeGregorio Family Foundation for Stomach and Esophageal Cancer Research, Pleasantville, New York, USA. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. · Division of Oncology, Stanford University School of Medicine, Stanford, California, USA. · Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands. · Division of Surgical Research, University of Zurich, Zurich, Suisse. · Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Institute of Pathology, Technische Universität, Munich, Germany. · Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Histopathology, Cambridge University Hospitals NHS Trust, Cambridge, UK. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Department of Pathology and Oncology, Medical Faculty of the University of Porto, Porto, Portugal. · NIHR Biomedical Research Unit, Nottingham Digestive Diseases Centre, Queens Medical Centre campus, Nottingham University Hospitals NHS Trust, Nottingham, UK. · Patient representative, The Netherlands. · Department of Oncology, Familial Gastric Cancer Registry, Cambridge University Hospital, Cambridge, UK. · Department of General Surgery and Surgical Oncology, University of Siena, Siena, Italy. · Department of Surgical Research, Technical University Dresden, Dresden, Germany. · Cambridge University Hospital, Cambridge, UK. · Stichting CDH1, The Netherlands. · Department of Medical Genetics, University of Cambridge, Cambridge, UK. · Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. · Department of Surgical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Radboud University Medical Center, Nijmegen, The Netherlands. · Cambridge NIHR Biomedical Research Centre, University of Cambridge NHS Foundation Trust MRC Cancer Unit, Hutchison/MRC Research Centre, Cambridge, UK Department Gastroenterology, Cambridge University Hospitals, UK. · Pubmed 25979631
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Level 4, Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, St James Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 26715442
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Department of Surgery & Cancer, Imperial College London, London, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Statistical Genomics Group, UCL Cancer Institute, University College London, London, UK. · Centre of Mathematics and Physics in Life & Experimental Sciences, University College London, London, UK. · Dundee Cancer Centre, Clinical Research Centre, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. · Pubmed 26280373
  • Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Dame Roma Mitchell Cancer Research Laboratories and the Adelaide Prostate Cancer Research Centre, School of Medicine, Hanson Institute Building, University of Adelaide, Adelaide, South Australia 5005, Australia. · Department of Urology, University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB7295, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [3] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Pubmed 26153859
  • Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Pubmed 25963740
  • Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · New address: University of California, San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Diagnostics, Genentech, Inc., South San Francisco, CA, USA. · Department of Diagnostics, Genentech, Inc., South San Francisco, CA, USA. · Afraxis, La Jolla, CA, USA. · New address: COI Pharmaceuticals, La Jolla, CA, USA. · Afraxis, La Jolla, CA, USA. · New address: COI Pharmaceuticals, La Jolla, CA, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · New address: Food and Drug Administration, Silver Spring, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · New address: aTyr Pharma, San Diego, CA, USA. · Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Biostatistics, Genentech, Inc., South San Francisco, CA, USA. · Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA. · Cancer Research UK, University of Cambridge, Cambridge, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Cancer Research UK, University of Cambridge, Cambridge, UK. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Discovery Chemistry, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · New address: Blueprint Medicines, Cambridge, MA, UK. · Pubmed 25902869
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Vesalius Research Center (VRC), Vib, Herestraat 49, 3000, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 3M7, Canada. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, USA. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Anatomical Pathology, The Alfred Hospital, Commercial Road, Melbourne, VIC, 3007, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Surgery, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Core Genotyping Facility, Frederick National Laboratory for Cancer Research, 8717 Grovemont Circle, Gaithersburg, MD, 20877, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentena 5, 02-781, Warsaw, Poland. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in Partnership with King's College London, Guy's Campus, SE1 1UL, London, UK. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · Saarland Cancer Registry, Präsident Baltz Strasse 5, 66119, Saarbrücken, Germany. · School of Medicine, Institute of Clinical Medicine, Oncology and Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Sydney, NSW 2145, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Peter Maccallum Cancer Center, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Sir Peter Maccallum Department of Oncology, University of Melbourne, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández, Almagro, 3, 28029, Madrid, Spain. · Centro de Investigación En Red De Enfermedades Raras (CIBERER), Calle de Álvaro de Bazán, 10 Bajo, 46010, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Frauenklinik der Stadtklinik Baden-Baden, Balger Strasse 50, 76532, Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133, Karlsruhe, Germany. · Department of Oncology - Pathology, Karolinska Institutet, Tomtebodavägen 23b, Stockholm, 171 65, Sweden. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, the University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK. · Early Detection Research Group, Division of Cancer Prevention National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Biology, University of Pisa, Lungarno Pacinotti 43, 56126, Pisa, Italy. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, 715 N Pleasant Street, Amherst, MA, 01002, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Genetics, Qimr Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 25897948
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; Department of Computer Science, University College London, London WC1E 6BT, UK; Centre of Mathematics and Physics in the Life Sciences and Experimental Biology, University College London, London WC1E 6BT, UK. · Department of Computer Science, University College London, London WC1E 6BT, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. · Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai 200031, China. · Pubmed 25793737
  • Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France. · Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France. · Faculté de Médecine, Aix-Marseille Université, Marseille, France. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Pubmed 25669979
  • Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK. · Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK [3] Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · Pubmed 25611378
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Cell Research and Immunology, George Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. · Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg 69120, Germany. · Kaplan Medical Center, Rehovot 76100, Israel. · Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. · INCPM, Weizmann Institute of Science, Rehovot 76100, Israel. · Faculty of Medicine, Bar-Ilan University, Safed 13115, Israel. · IPATIMUP, University of Porto, Porto 4200-465, Portugal. · Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA. · The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan 52900, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 25605973
  • 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2] Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK [3]. · 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2]. · Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · SAIC-Frederic, National Cancer Institute-Frederick, Frederick, Maryland 21701, USA. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK. · The Methodist Hospital Research Institute, 6670 Bertner Street, Houston, Texas 77030, USA. · Molecular Oncology Department, BC Cancer Agency Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK [3] Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Pubmed 25574598
  • Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Chromatin and Gene Expression Section, Research Triangle Park, Durham, NC, 27709, USA. · Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, 27709, USA. · Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shin Centre, Cambridge, CB2 0RE, UK. · Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Pubmed 25572802
  • 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK [2] Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · 1] Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada [2] Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. · 1] Department of Experimental Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada. · Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada [2] Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [2] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 25470049
  • Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Computer Science, Princeton University, Princeton New Jersey. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Five3 Genomics, Inc., Santa Cruz, California. · Lady Davis Institute for Medical Research, Montreal, Québec, Canada. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation, Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Ahus, Norway. · Pubmed 25351767
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge. · Department of Oncology and Strangeways Research Laboratory, University of Cambridge. Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Pubmed 26133777
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
  • Department of Genetics, Institute for Cancer Research and Department of Pathology, Oslo University Hospital, Oslo, Norway K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 25471453
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · 1] Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia [2] School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire 03755, USA. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, 1066 CX Amsterdam, The Netherlands. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark [3] Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · 1] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium. · 1] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium [2] Vesalius Research Center, University of Leuven, 3000 Leuven, Belgium. · 1] Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Clinical Genetics, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea [3] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea. · Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · 1] Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 94807 Villejuif, France [2] University Paris-Sud, UMRS 1018, 94807 Villejuif, France. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. · 1] Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010 Valencia, Spain [2] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, 33012 Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, 33013 Oviedo, Spain. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Shanghai Center for Disease Control and Prevention, Shanghai 200336, China. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, China. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · 1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8. · 1] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada M5T 3M7 [2] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's &St Thomas' NHS Foundation Trust in partnership with King's College London, London SE1 9RT, UK. · Wellcome Trust Centre for Human Genetics, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Galway, Ireland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia [2] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Singapore Eye Research Institute, National University of Singapore, Singapore 168751, Singapore. · Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, 3075 EA Rotterdam, The Netherlands. · Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria 3010, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] College of Public Health, China Medical University, Taichung 40402, Taiwan, China [2] Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, China. · Department of Surgery, Changhua Christian Hospital, Changhua City 500, Taiwan, China. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway. · 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia. · Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria 3004, Australia. · 1] Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK [2] Institute of Population Health, University of Manchester, Manchester M13 9PL, UK. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK. · Ministry of Public Health, Bangkok 10400, Thailand. · 1] Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Division of General Surgery, National University Health System, Singapore 117597, Singapore. · 1] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore [2] Department of Statistics and Applied Probability, National University of Singapore, Singapore 117546, Singapore. · 1] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA [2] Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Saarland Cancer Registry, 66119 Saarbrücken, Germany. · 1] Division of Breast Cancer Research, Institute of Cancer Research, London SM2 5NG, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · 1] Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada G1V 4G2. · 1] Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1 [2] Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A8. · Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada H3T 1A8. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, NordLab Oulu/Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany [2] University of Tübingen, 72074 Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), 20141 Milan, Italy. · 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy [2] Cogentech Cancer Genetic Test Laboratory, 20133 Milan, Italy. · Department of Obstetrics and Gynaecology, Hannover Medical School, 30625 Hannover, Germany. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, FI-70210 Kuopio, Finland [3] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · Department of Human Genetics &Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, 3075 EA Rotterdam, The Netherlands. · Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens 15310, Greece. · National Cancer Institute, Bangkok 10400, Thailand. · International Agency for Research on Cancer, Lyon, Cedex 08, France. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Bogota, DC 11001000, Colombia. · Department of Epidemiology, University of California Irvine, Irvine, California 92697, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 92697, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Centre d'innovation Génome Québec et Université McGill, Montréal, Quebec, Canada H3A OG1. · McGill University, Montreal, Quebec, Canada H3A OG1. · Cancer Research UK, Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 1L7. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), University of Oslo (UiO), 0450 Oslo, Norway. · 1] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Pubmed 25248036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Five3 Genomics, Santa Cruz, CA 95060, USA. · Stanford Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; San Raffaele University, 20132 Milan, Italy. · Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Thomson Reuters Healthcare & Science, Encinitas, CA 92024, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: · Pubmed 24937458
  • Department of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [3] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · 1] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Institute for Medical Informatics, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · 1] Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] Cambridge Breast Unit, Addenbrooke's Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 24901235
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. · NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Laboratory of Molecular Gerontology, Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224-6825, USA. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24880630
  • K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Cancer Medicine, Surgery and Transplantation, Department of Oncology, Oslo University Hospital, Oslo; · Cancer Research UK, Cambridge Institute; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Department of Pathology and Laboratory Medicine, University of British Colombia; and Molecular Oncology, British Colombia Cancer Research Center, Vancouver, Canada. · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Medicine, Department of Clinical Molecular Oncology, Akershus University Hospital, Lørenskog, Norway; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; · Cancer Research UK, Cambridge Institute; Cambridge Experimental Cancer Medicine Centre; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Pubmed 24803582
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
  • Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Molecular Oncology, British Columbia Cancer Agency, 675 West 10(th) Avenue, V5Z 1L3 Vancouver, Canada. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital, NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cambridge Experimental Cancer Medicine Centre (ECMC), Cambridge CB2 0RE, UK. · Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. Electronic address: · Pubmed 24582497
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Division of Oncology, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24462520
2013
  • Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, United States of America. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Departments of Statistics, Ecology and Evolution, Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois, United States of America. · Pubmed 24349199
  • Cancer Research, UK Cambridge Institute, New Orleans, LA 70124, USA. · Pubmed 23800190
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23380999
2011
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 21944024
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2015
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK (QG, JT, AMD, MS, JEA, DFE, PDPP) · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, SC, AB, FBH) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, SH, DJH, SL) · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, CCh, DJH, SL) · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland (SK, RF, TAM, HN) · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (MKB, QW, JD, KM, ML, SK, DFE, PDPP) · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (JBee, GCT) · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden (KC, HD, ME, JiL, JBr, KH, PH) · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium (DL) · Vesalius Research Center, VIB, Leuven, Belgium (DL) · Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium (CW, KL) · Copenhagen General Population Study, Herlev Hospital, Copenhagen, Denmark (SEB, BGN, SFN) · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Denmark (SEB, BGN, SFN) · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (SEB, BGN) · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Denmark (HF) · Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany (JCC, AR, PS, DC, AHü, RK, MB) · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany (DFJ) · Department of Oncology · Pubmed 25890600
2014
  • Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK. · Pubmed 25472026
  • Authors' Affiliations: Department of Oncology and Strangeways Research Laboratory, University of Cambridge; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; Cambridge Experimental Cancer Medicine Centre, Cambridge; Warwick Clinical Trials Unit, University of Warwick; and Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Pubmed 24599932
2013
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Box 97, Cambridge CB4 3EJ, UK. · Pubmed 23800221
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • Department of Oncology Box 193, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 23299526
  • 1] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] [4]. · Pubmed 24043118
  • Cambridge Breast Unit, Box 97, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 23736032
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23644459
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Pubmed 23635078
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Pubmed 23483540
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 23329232
2012
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, UK. · Pubmed 23047592
  • Hutchison/MRC Research Centre and Department of Pathology, University of Cambridge, Cambridge, UK. · Pubmed 23260012
  • Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK. · Pubmed 22850554
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 22538974
  • Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK. · Pubmed 22522925
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, UK. · Pubmed 22294324
  • Department of Oncology, University of Cambridge, Cambridge, CB1 9RN, UK. · Pubmed 21953021
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, United Kingdom. · Pubmed 21788678
2011
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 22112299
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom. · Pubmed 21527579
  • Cambridge Breast Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK. · Pubmed 21371853
  • Strangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, Wort's Causeway, Cambridge CB1 8RN, UK. · Pubmed 21266980
2010
  • Breast Cancer Functional Genomics Laboratory, Department of Oncology University of Cambridge, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 21050467
  • Department of Oncology, Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Pubmed 20731819
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 20664598
Probable:    University of London      
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, 94305, CA, USA. · Department of Pathology, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Department of Biology, Stanford University, Stanford, 94305, CA, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Maimonides Medical Center, Brooklyn, 11219, NY, USA. · Norris Comprehensive Cancer Center, Los Angeles, 90033, CA, USA. · Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. · Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 90333, CA, USA. · Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA. · Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Pubmed 30737380
  • Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, United Kingdom. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden. · Department of Pathology, Academic Medical Center, 1105AZ Amsterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Département de Biopathologie, Institut Bergonié, CS 61283 33076 Bordeaux, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium. · Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium. · Molecular Immunology Unit, Jules Bordet Institute, B-1000 Brussels, Belgium. · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Department of Radiation Oncology, and Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, 4029 Brisbane, Australia. · Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium. · Istituto Tumori G Paolo II, IRCCS, 70124 Bari, Italy. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. · Institut Curie, Department of Pathology and INSERM U934, 75248 Paris Cedex 05, France. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 38330 Montbonnot-Saint Martin, France. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radiumhospital, 0310 Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, 0310 Oslo, Norway. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands. · Pubmed 30692147
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 30520388
2018
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
  • The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Academic Urology Group, Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Institute of Molecular Biology (IMB), Mainz, Germany. · Department of Biochemistry, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Hinxton, UK. · AstraZeneca, Waltham, MA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · AstraZeneca, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Pubmed 30022119
  • Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. · Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford, CA 94305, USA. · Stanford Cancer Institute, Stanford, CA 94305, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Breast Cancer Program, CRUK Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA; California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA; San Francisco Veterans Affairs Medical Center, San Francisco, San Francisco, CA 94121, USA. · Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. Electronic address: · Pubmed 29731168
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. · The Smoler Protein Center, Department of Biology, Technion, Haifa 32000, Israel. · Cancer Research UK Cambridge Institute and the Cambridge Cancer Centre, Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. · Department of Immunology and Cancer Research and Department Pathology, Hebrew University-Hadassah Medical School, Jerusalem 91010, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 29382783
2017
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Pathology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Computer Science, University of Oslo, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Medicine, University of Oslo, Oslo, Norway. · Department of Oncology, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. Electronic address: · Pubmed 28733194
  • Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. · Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. Electronic address: · Pubmed 28694015
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Department of Pathology, College of Medicine, Al Mustansiriyah University, Baghdad, Iraq. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Pubmed 28478613
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway. · Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. · Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Five3 Genomics, LLC, Santa Cruz, CA, 95060, USA. · Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Surgery, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. · Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway. · Department of Pathology, Akershus University Hospital, Lørenskog, Norway. · Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 28356166
  • Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 27648723
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Pubmed 26776681
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. · Cancer Research UK, Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · CCR Collaborative Bioinformatics Resource, Advanced Biomedical Computing Center, Leidos Biomed, Frederick National Laboratory, Frederick, MD, USA. · Breakthrough Breast Cancer Unit, Institute of Cancer Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK. · Pubmed 27181204
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, United Kingdom. · Department of Breast and Endocrine Surgery, Akershus University Hospital, Lorenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Department of Informatics, University of Oslo, Oslo, Norway. · Institute of Cancer Genetics and Informatics, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Pubmed 27082076
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. · Cellular Pathology, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK. · Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE. · Pubmed 26954716
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Present address: Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, UK. · Royal Bournemouth Hospital and Bournemouth University, Castle Lane East, Bournemouth, UK. · Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, Peterborough, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Pubmed 26882907
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Level 4, Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, St James Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 26715442
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Department of Surgery & Cancer, Imperial College London, London, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Statistical Genomics Group, UCL Cancer Institute, University College London, London, UK. · Centre of Mathematics and Physics in Life & Experimental Sciences, University College London, London, UK. · Dundee Cancer Centre, Clinical Research Centre, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. · Pubmed 26280373
  • Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Dame Roma Mitchell Cancer Research Laboratories and the Adelaide Prostate Cancer Research Centre, School of Medicine, Hanson Institute Building, University of Adelaide, Adelaide, South Australia 5005, Australia. · Department of Urology, University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB7295, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [3] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Pubmed 26153859
  • Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Pubmed 25963740
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Vesalius Research Center (VRC), Vib, Herestraat 49, 3000, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 3M7, Canada. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, USA. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Anatomical Pathology, The Alfred Hospital, Commercial Road, Melbourne, VIC, 3007, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Surgery, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Core Genotyping Facility, Frederick National Laboratory for Cancer Research, 8717 Grovemont Circle, Gaithersburg, MD, 20877, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentena 5, 02-781, Warsaw, Poland. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in Partnership with King's College London, Guy's Campus, SE1 1UL, London, UK. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · Saarland Cancer Registry, Präsident Baltz Strasse 5, 66119, Saarbrücken, Germany. · School of Medicine, Institute of Clinical Medicine, Oncology and Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Sydney, NSW 2145, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Peter Maccallum Cancer Center, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Sir Peter Maccallum Department of Oncology, University of Melbourne, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández, Almagro, 3, 28029, Madrid, Spain. · Centro de Investigación En Red De Enfermedades Raras (CIBERER), Calle de Álvaro de Bazán, 10 Bajo, 46010, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Frauenklinik der Stadtklinik Baden-Baden, Balger Strasse 50, 76532, Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133, Karlsruhe, Germany. · Department of Oncology - Pathology, Karolinska Institutet, Tomtebodavägen 23b, Stockholm, 171 65, Sweden. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, the University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK. · Early Detection Research Group, Division of Cancer Prevention National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Biology, University of Pisa, Lungarno Pacinotti 43, 56126, Pisa, Italy. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, 715 N Pleasant Street, Amherst, MA, 01002, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Genetics, Qimr Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 25897948
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; Department of Computer Science, University College London, London WC1E 6BT, UK; Centre of Mathematics and Physics in the Life Sciences and Experimental Biology, University College London, London WC1E 6BT, UK. · Department of Computer Science, University College London, London WC1E 6BT, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. · Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai 200031, China. · Pubmed 25793737
  • Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France. · Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France. · Faculté de Médecine, Aix-Marseille Université, Marseille, France. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Pubmed 25669979
  • Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK. · Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK [3] Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · Pubmed 25611378
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Cell Research and Immunology, George Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. · Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg 69120, Germany. · Kaplan Medical Center, Rehovot 76100, Israel. · Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. · INCPM, Weizmann Institute of Science, Rehovot 76100, Israel. · Faculty of Medicine, Bar-Ilan University, Safed 13115, Israel. · IPATIMUP, University of Porto, Porto 4200-465, Portugal. · Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA. · The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan 52900, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 25605973
  • 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2] Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK [3]. · 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2]. · Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · SAIC-Frederic, National Cancer Institute-Frederick, Frederick, Maryland 21701, USA. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK. · The Methodist Hospital Research Institute, 6670 Bertner Street, Houston, Texas 77030, USA. · Molecular Oncology Department, BC Cancer Agency Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK [3] Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Pubmed 25574598
  • Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Chromatin and Gene Expression Section, Research Triangle Park, Durham, NC, 27709, USA. · Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, 27709, USA. · Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shin Centre, Cambridge, CB2 0RE, UK. · Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Pubmed 25572802
  • 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK [2] Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · 1] Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada [2] Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. · 1] Department of Experimental Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada. · Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada [2] Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [2] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 25470049
  • Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Computer Science, Princeton University, Princeton New Jersey. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Five3 Genomics, Inc., Santa Cruz, California. · Lady Davis Institute for Medical Research, Montreal, Québec, Canada. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation, Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Ahus, Norway. · Pubmed 25351767
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge. · Department of Oncology and Strangeways Research Laboratory, University of Cambridge. Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Pubmed 26133777
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
  • Department of Genetics, Institute for Cancer Research and Department of Pathology, Oslo University Hospital, Oslo, Norway K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 25471453
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · 1] Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia [2] School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire 03755, USA. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, 1066 CX Amsterdam, The Netherlands. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark [3] Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · 1] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium. · 1] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium [2] Vesalius Research Center, University of Leuven, 3000 Leuven, Belgium. · 1] Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Clinical Genetics, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea [3] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea. · Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · 1] Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 94807 Villejuif, France [2] University Paris-Sud, UMRS 1018, 94807 Villejuif, France. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. · 1] Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010 Valencia, Spain [2] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, 33012 Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, 33013 Oviedo, Spain. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Shanghai Center for Disease Control and Prevention, Shanghai 200336, China. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, China. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · 1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8. · 1] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada M5T 3M7 [2] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's &St Thomas' NHS Foundation Trust in partnership with King's College London, London SE1 9RT, UK. · Wellcome Trust Centre for Human Genetics, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Galway, Ireland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia [2] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Singapore Eye Research Institute, National University of Singapore, Singapore 168751, Singapore. · Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, 3075 EA Rotterdam, The Netherlands. · Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria 3010, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] College of Public Health, China Medical University, Taichung 40402, Taiwan, China [2] Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, China. · Department of Surgery, Changhua Christian Hospital, Changhua City 500, Taiwan, China. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway. · 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia. · Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria 3004, Australia. · 1] Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK [2] Institute of Population Health, University of Manchester, Manchester M13 9PL, UK. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK. · Ministry of Public Health, Bangkok 10400, Thailand. · 1] Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Division of General Surgery, National University Health System, Singapore 117597, Singapore. · 1] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore [2] Department of Statistics and Applied Probability, National University of Singapore, Singapore 117546, Singapore. · 1] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA [2] Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Saarland Cancer Registry, 66119 Saarbrücken, Germany. · 1] Division of Breast Cancer Research, Institute of Cancer Research, London SM2 5NG, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · 1] Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada G1V 4G2. · 1] Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1 [2] Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A8. · Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada H3T 1A8. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, NordLab Oulu/Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany [2] University of Tübingen, 72074 Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), 20141 Milan, Italy. · 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy [2] Cogentech Cancer Genetic Test Laboratory, 20133 Milan, Italy. · Department of Obstetrics and Gynaecology, Hannover Medical School, 30625 Hannover, Germany. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, FI-70210 Kuopio, Finland [3] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · Department of Human Genetics &Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, 3075 EA Rotterdam, The Netherlands. · Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens 15310, Greece. · National Cancer Institute, Bangkok 10400, Thailand. · International Agency for Research on Cancer, Lyon, Cedex 08, France. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Bogota, DC 11001000, Colombia. · Department of Epidemiology, University of California Irvine, Irvine, California 92697, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 92697, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Centre d'innovation Génome Québec et Université McGill, Montréal, Quebec, Canada H3A OG1. · McGill University, Montreal, Quebec, Canada H3A OG1. · Cancer Research UK, Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 1L7. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), University of Oslo (UiO), 0450 Oslo, Norway. · 1] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Pubmed 25248036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Five3 Genomics, Santa Cruz, CA 95060, USA. · Stanford Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; San Raffaele University, 20132 Milan, Italy. · Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Thomson Reuters Healthcare & Science, Encinitas, CA 92024, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: · Pubmed 24937458
  • Department of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [3] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · 1] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Institute for Medical Informatics, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · 1] Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] Cambridge Breast Unit, Addenbrooke's Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 24901235
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. · NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Laboratory of Molecular Gerontology, Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224-6825, USA. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24880630
  • K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Cancer Medicine, Surgery and Transplantation, Department of Oncology, Oslo University Hospital, Oslo; · Cancer Research UK, Cambridge Institute; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Department of Pathology and Laboratory Medicine, University of British Colombia; and Molecular Oncology, British Colombia Cancer Research Center, Vancouver, Canada. · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Medicine, Department of Clinical Molecular Oncology, Akershus University Hospital, Lørenskog, Norway; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; · Cancer Research UK, Cambridge Institute; Cambridge Experimental Cancer Medicine Centre; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Pubmed 24803582
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
  • Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Molecular Oncology, British Columbia Cancer Agency, 675 West 10(th) Avenue, V5Z 1L3 Vancouver, Canada. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital, NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cambridge Experimental Cancer Medicine Centre (ECMC), Cambridge CB2 0RE, UK. · Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. Electronic address: · Pubmed 24582497
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Division of Oncology, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24462520
2013
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23380999
2011
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 21944024
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2014
  • Authors' Affiliations: Department of Oncology and Strangeways Research Laboratory, University of Cambridge; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; Cambridge Experimental Cancer Medicine Centre, Cambridge; Warwick Clinical Trials Unit, University of Warwick; and Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Pubmed 24599932
2013
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • 1] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] [4]. · Pubmed 24043118
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23644459
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Pubmed 23635078
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
2012
  • Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK. · Pubmed 23100629
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, UK. · Pubmed 22294324
2010
  • Breast Cancer Functional Genomics Laboratory, Department of Oncology University of Cambridge, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 21050467
Probable:    Miscellaneous institutions in Cambridge, UK      
2018
  • Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Department of Life Sciences, Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. · Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 30507376
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
2017
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK. · Pathology Department, Faculty of Medicine, Menoufyia University, Menoufyia 110532, Egypt. · Cancer Research UK, Cambridge Research Institute, Cambridge CB 0RE, UK. · Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il 2440, Saudi Arabia. · Department of Biology, Georgia State University, Atlanta, GA 30303, USA. · Pubmed 28829761
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy & Developmental Biology, Monash University, Clayton, VIC, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Research and Development, Lincoln Breast Unit, Lincoln County Hospital, Lincoln, UK. · Nottingham Digestive Disease Centre, Faculty of Medicine and Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. · PathLinks, Lincoln County Hospital, Lincoln, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 28697743
  • 1 MRC Biostatistics Unit, Cambridge, UK. · 2 Cancer Research UK Cambridge Institute, Cambridge, UK. · 3 Department of Pathology, University of Cambridge, Cambridge, UK. · 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · 5 Department of Oncology, University of Cambridge, Cambridge, UK. · 6 NIH Cambridge Biomedical Research Centre, Cambridge, UK. · 7 Strangeways Research Laboratory, Cambridge, UK. · Pubmed 25193065
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, United Kingdom. · Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, Leeds, United Kingdom. · Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. · Pubmed 27392074
  • Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. · John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK. · Liggins Institute, University of Auckland, Auckland, New Zealand; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Liggins Institute, University of Auckland, Auckland, New Zealand. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: · Pubmed 27312051
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 27542606
  • Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK. · Department of Pathology, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt. · Department of Oncology, Azadi Teaching Hospital, Duhok, Kurdistan, 1014 AM, Iraq. · Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il, Saudi Arabia. · Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK. · Department of Surgery and Cancer, Imperial College London, London, UK. · Centre for the Cambridge Experimental Cancer Medicine Centre (ECMC) and Cambridge Breast Cancer Research Unit, Cambridge, UK. · Department of Pathology, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt. · Pubmed 27514395
  • Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA. · Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA. · Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA. · MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK. · GlaxoSmithKline, Collegeville, PA, 19425, USA. · Cytokinetics, Inc., South San Francisco, CA, 94080, USA. · Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada. · Cancer Research UK, Cambridge Institute, Cambridge, UK. · Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. · Pubmed 27368372
2015
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Academic Haematology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK; Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. Electronic address: · Pubmed 25205036
  • Dame Roma Mitchell Cancer Research Laboratories, Discipline of Medicine, The University of Adelaide, SA 5005, Australia. · Computational Biology Program, Public Health Sciences Division, Seattle, WA 98109, USA. · Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Bedford Park, SA 5042, Australia. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55905, USA. · Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55905, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, SA 5005, Australia. · Pubmed 26554309
  • Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. · Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · MTA TTK Lendület Cancer Biomarker Research Group, Second Department of Pediatrics, Semmelweis University and MTA-SE Pediatrics and Nephrology Research Group, Budapest 1085, Hungary. · MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. · Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. Electronic address: · Pubmed 26411678
  • Department of Oncology, University of Cambridge, Cambridge, UK ; Department of Gynecology and Obstetrics, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil. · Department of Physics (Astrophysics), University of Oxford, Oxford, UK. · Cancer Research UK, Cambridge Institute, Cambridge, UK. · University of Southampton, Southampton, UK. · University of Leeds, Leeds, UK. · Addenbrookes Hospital NHS Trust, Cambridge, UK. · Institute of Cancer Research, London, UK. · Cancer Research UK, London, UK. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Oncology, University of Cambridge, Cambridge, UK ; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain ; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia ; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Finland. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Oncology, University of Cambridge, Cambridge, UK. · National Cancer Institute, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany ; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany ; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Pubmed 26288840
  • Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada5Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada. · Expression Regulation in Cancer Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada. · Division of Anatomical Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada. · The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada9Rosalind and Morris Goodman Cancer Research Centre, Montreal, Quebec, Canada. · Human Reproduction Service, University Hospitals of Coimbra, Coimbra, Portugal11Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Lisbon Portugal. · Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada. · Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Frauenshuh Cancer Center, Park Nicollet Clinic, St Louis Park, Minnesota. · Cancer Research UK Cambridge Institute, Cambridge, England. · Provincial Medical Genetics Program, St John's, Newfoundland, Canada. · Department of Health Science Research, Mayo Clinic, Scottsdale, Arizona. · Cancer Care Program, Dr. H. Bliss Murphy Cancer Centre Eastern Health, St John's, Newfoundland, Canada. · Institute of Pathology, Technische Universität München, München, Germany. · Creighton's Hereditary Cancer Center, Omaha, Nebraska. · Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada22Samuel Lunenfeld Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada. · Department of Experimental Oncology, European Institute of Oncology, Milano, Italy24Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy. · Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy25Istituto Toscano Tumori (ITT), University Hospital of Siena, Siena, Italy. · Expression Regulation in Cancer Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal26Faculty of Medicine, University of Porto, Porto, Portugal. · Department of Oncology, University of Cambridge, Strangeway's Research Laboratory, Wort's Causeway, Cambridge, England28Department of Public Health and Primary Care, University of Cambridge, Strangeway's Research Laboratory, Wort's Causeway, Cambridge, En. · Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular. · Pubmed 26182300
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Cancer Research UK Cambridge Research Institute Li Ka Shing Centre, Cambridge, UK. · Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel. · Chemical Physics, Weizmann Institute of Science, Rehovot, Israel. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg, Germany. · Biological Services, Weizmann Institute of Science, Rehovot, Israel. · IPATIMUP - Institute of Molecular Pathology and Immunology, Medical Faculty of the University of Porto, Porto, Portugal. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel · Pubmed 25678558
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2013
  • Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23412800
  • Cambridge Research Institute, Cancer Research UK, Cambridge, United Kingdom. · Pubmed 24069272
  • Cancer Research UK, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23871723
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23403292
2012
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Pubmed 22968701
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 22217937
2011
  • Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge, UK. · Pubmed 22128823
  • Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Pubmed 21337521
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 147 total) written by Carlos Caldas about Breast Neoplasms:

  • The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. 2019
  • 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. 2019
  • Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy. 2019
  • The circular RNome of primary breast cancer. 2019
  • miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth. 2019
  • Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis. 2018
  • A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. 2018
  • SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis. 2018
  • Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. 2018
  • Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element. 2018
Show List of Full Article Records
Google Searches

Learn more about Carlos Caldas using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Cambridge
University of London
Miscellaneous institutions in Cambridge, UK
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Cambridge
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, 94305, CA, USA. · Department of Pathology, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Department of Biology, Stanford University, Stanford, 94305, CA, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Maimonides Medical Center, Brooklyn, 11219, NY, USA. · Norris Comprehensive Cancer Center, Los Angeles, 90033, CA, USA. · Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. · Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 90333, CA, USA. · Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA. · Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Pubmed 30737380
  • Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, United Kingdom. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden. · Department of Pathology, Academic Medical Center, 1105AZ Amsterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Département de Biopathologie, Institut Bergonié, CS 61283 33076 Bordeaux, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium. · Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium. · Molecular Immunology Unit, Jules Bordet Institute, B-1000 Brussels, Belgium. · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Department of Radiation Oncology, and Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, 4029 Brisbane, Australia. · Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium. · Istituto Tumori G Paolo II, IRCCS, 70124 Bari, Italy. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. · Institut Curie, Department of Pathology and INSERM U934, 75248 Paris Cedex 05, France. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 38330 Montbonnot-Saint Martin, France. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radiumhospital, 0310 Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, 0310 Oslo, Norway. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands. · Pubmed 30692147
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 30520388
2018
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
  • The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Academic Urology Group, Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Institute of Molecular Biology (IMB), Mainz, Germany. · Department of Biochemistry, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Hinxton, UK. · AstraZeneca, Waltham, MA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · AstraZeneca, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Pubmed 30022119
  • Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. · Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford, CA 94305, USA. · Stanford Cancer Institute, Stanford, CA 94305, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Breast Cancer Program, CRUK Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA; California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA; San Francisco Veterans Affairs Medical Center, San Francisco, San Francisco, CA 94121, USA. · Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. Electronic address: · Pubmed 29731168
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. · The Smoler Protein Center, Department of Biology, Technion, Haifa 32000, Israel. · Cancer Research UK Cambridge Institute and the Cambridge Cancer Centre, Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. · Department of Immunology and Cancer Research and Department Pathology, Hebrew University-Hadassah Medical School, Jerusalem 91010, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 29382783
  • CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Novocraft Technologies Sdn Bhd, C-23A-05, 3 Two Square, Jalan 19/1, Section 19, 46300, Petaling Jaya, Selangor Darul Ehsan, Malaysia. · CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Pubmed 29304755
2017
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Pathology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Computer Science, University of Oslo, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Medicine, University of Oslo, Oslo, Norway. · Department of Oncology, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. Electronic address: · Pubmed 28733194
  • Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. · Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. Electronic address: · Pubmed 28694015
  • Li Ka Shing Centre, Cancer Research UK Cambridge Institute. · Department of Pathology. · Institute of Astronomy, University of Cambridge, Cambridge. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 28525534
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy & Developmental Biology, Monash University, Clayton, VIC, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Research and Development, Lincoln Breast Unit, Lincoln County Hospital, Lincoln, UK. · Nottingham Digestive Disease Centre, Faculty of Medicine and Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. · PathLinks, Lincoln County Hospital, Lincoln, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 28697743
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Department of Pathology, College of Medicine, Al Mustansiriyah University, Baghdad, Iraq. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Pubmed 28478613
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway. · Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. · Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Five3 Genomics, LLC, Santa Cruz, CA, 95060, USA. · Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Surgery, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. · Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway. · Department of Pathology, Akershus University Hospital, Lørenskog, Norway. · Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 28356166
  • Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 27648723
  • 1 MRC Biostatistics Unit, Cambridge, UK. · 2 Cancer Research UK Cambridge Institute, Cambridge, UK. · 3 Department of Pathology, University of Cambridge, Cambridge, UK. · 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · 5 Department of Oncology, University of Cambridge, Cambridge, UK. · 6 NIH Cambridge Biomedical Research Centre, Cambridge, UK. · 7 Strangeways Research Laboratory, Cambridge, UK. · Pubmed 25193065
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Pubmed 26776681
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, United Kingdom. · Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, Leeds, United Kingdom. · Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. · Pubmed 27392074
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 27542606
  • Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, South Australia, Australia. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Breast Cancer Genomics Group, Cancer Research UK, Cambridge Institute, Cambridge University, Cambridge, United Kingdom. · Nuclear Transcription Factor Laboratory, Cancer Research UK, Cambridge Institute, Cambridge University, Cambridge, United Kingdom. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 27496708
  • Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. · Cancer Research UK, Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · CCR Collaborative Bioinformatics Resource, Advanced Biomedical Computing Center, Leidos Biomed, Frederick National Laboratory, Frederick, MD, USA. · Breakthrough Breast Cancer Unit, Institute of Cancer Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK. · Pubmed 27181204
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, United Kingdom. · Department of Breast and Endocrine Surgery, Akershus University Hospital, Lorenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Department of Informatics, University of Oslo, Oslo, Norway. · Institute of Cancer Genetics and Informatics, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Pubmed 27082076
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. · Cellular Pathology, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK. · Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE. · Pubmed 26954716
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Present address: Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, UK. · Royal Bournemouth Hospital and Bournemouth University, Castle Lane East, Bournemouth, UK. · Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, Peterborough, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Pubmed 26882907
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Department of Pathology and Oncology, Medical Faculty of the University of Porto, Porto, Portugal Centro Hospitalar São João, Porto, Portugal. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, University of Cambridge, Cambridge, UK. · No Stomach For Cancer, Inc., Madison, Wisconsin, USA. · Department of Oesophago-Gastric Surgery, Addenbrooke's Hospital, Cambridge, UK. · Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgical Gastroenterology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands. · Vinery Lane Surgery, Whangarei, New Zealand. · Division of Psychosocial Research and Epidemiology/Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Gastroenterology and Hepatology, Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · The DeGregorio Family Foundation for Stomach and Esophageal Cancer Research, Pleasantville, New York, USA. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. · Division of Oncology, Stanford University School of Medicine, Stanford, California, USA. · Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands. · Division of Surgical Research, University of Zurich, Zurich, Suisse. · Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Institute of Pathology, Technische Universität, Munich, Germany. · Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Histopathology, Cambridge University Hospitals NHS Trust, Cambridge, UK. · Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal Department of Pathology and Oncology, Medical Faculty of the University of Porto, Porto, Portugal. · NIHR Biomedical Research Unit, Nottingham Digestive Diseases Centre, Queens Medical Centre campus, Nottingham University Hospitals NHS Trust, Nottingham, UK. · Patient representative, The Netherlands. · Department of Oncology, Familial Gastric Cancer Registry, Cambridge University Hospital, Cambridge, UK. · Department of General Surgery and Surgical Oncology, University of Siena, Siena, Italy. · Department of Surgical Research, Technical University Dresden, Dresden, Germany. · Cambridge University Hospital, Cambridge, UK. · Stichting CDH1, The Netherlands. · Department of Medical Genetics, University of Cambridge, Cambridge, UK. · Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands. · Department of Surgical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Radboud University Medical Center, Nijmegen, The Netherlands. · Cambridge NIHR Biomedical Research Centre, University of Cambridge NHS Foundation Trust MRC Cancer Unit, Hutchison/MRC Research Centre, Cambridge, UK Department Gastroenterology, Cambridge University Hospitals, UK. · Pubmed 25979631
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Level 4, Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, St James Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 26715442
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Department of Surgery & Cancer, Imperial College London, London, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Statistical Genomics Group, UCL Cancer Institute, University College London, London, UK. · Centre of Mathematics and Physics in Life & Experimental Sciences, University College London, London, UK. · Dundee Cancer Centre, Clinical Research Centre, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. · Pubmed 26280373
  • Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Dame Roma Mitchell Cancer Research Laboratories and the Adelaide Prostate Cancer Research Centre, School of Medicine, Hanson Institute Building, University of Adelaide, Adelaide, South Australia 5005, Australia. · Department of Urology, University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB7295, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [3] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Pubmed 26153859
  • Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Pubmed 25963740
  • Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · New address: University of California, San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Department of Diagnostics, Genentech, Inc., South San Francisco, CA, USA. · Department of Diagnostics, Genentech, Inc., South San Francisco, CA, USA. · Afraxis, La Jolla, CA, USA. · New address: COI Pharmaceuticals, La Jolla, CA, USA. · Afraxis, La Jolla, CA, USA. · New address: COI Pharmaceuticals, La Jolla, CA, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · New address: Food and Drug Administration, Silver Spring, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · National Center for Advancing Translational Sciences, Bethesda, MD, USA. · New address: aTyr Pharma, San Diego, CA, USA. · Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Biostatistics, Genentech, Inc., South San Francisco, CA, USA. · Department of Bioinformatics, Genentech, Inc., South San Francisco, CA, USA. · Cancer Research UK, University of Cambridge, Cambridge, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals, Nottingham, UK. · Cancer Research UK, University of Cambridge, Cambridge, UK. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · Department of Pathology, Genentech, Inc., South San Francisco, CA, USA. · Discovery Chemistry, Genentech, Inc., South San Francisco, CA, USA. · Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA. · New address: Blueprint Medicines, Cambridge, MA, UK. · Pubmed 25902869
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Vesalius Research Center (VRC), Vib, Herestraat 49, 3000, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 3M7, Canada. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, USA. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Anatomical Pathology, The Alfred Hospital, Commercial Road, Melbourne, VIC, 3007, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Surgery, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Core Genotyping Facility, Frederick National Laboratory for Cancer Research, 8717 Grovemont Circle, Gaithersburg, MD, 20877, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentena 5, 02-781, Warsaw, Poland. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in Partnership with King's College London, Guy's Campus, SE1 1UL, London, UK. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · Saarland Cancer Registry, Präsident Baltz Strasse 5, 66119, Saarbrücken, Germany. · School of Medicine, Institute of Clinical Medicine, Oncology and Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Sydney, NSW 2145, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Peter Maccallum Cancer Center, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Sir Peter Maccallum Department of Oncology, University of Melbourne, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández, Almagro, 3, 28029, Madrid, Spain. · Centro de Investigación En Red De Enfermedades Raras (CIBERER), Calle de Álvaro de Bazán, 10 Bajo, 46010, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Frauenklinik der Stadtklinik Baden-Baden, Balger Strasse 50, 76532, Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133, Karlsruhe, Germany. · Department of Oncology - Pathology, Karolinska Institutet, Tomtebodavägen 23b, Stockholm, 171 65, Sweden. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, the University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK. · Early Detection Research Group, Division of Cancer Prevention National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Biology, University of Pisa, Lungarno Pacinotti 43, 56126, Pisa, Italy. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, 715 N Pleasant Street, Amherst, MA, 01002, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Genetics, Qimr Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 25897948
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; Department of Computer Science, University College London, London WC1E 6BT, UK; Centre of Mathematics and Physics in the Life Sciences and Experimental Biology, University College London, London WC1E 6BT, UK. · Department of Computer Science, University College London, London WC1E 6BT, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. · Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai 200031, China. · Pubmed 25793737
  • Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France. · Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France. · Faculté de Médecine, Aix-Marseille Université, Marseille, France. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Pubmed 25669979
  • Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK. · Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK [3] Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · Pubmed 25611378
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Cell Research and Immunology, George Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. · Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg 69120, Germany. · Kaplan Medical Center, Rehovot 76100, Israel. · Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. · INCPM, Weizmann Institute of Science, Rehovot 76100, Israel. · Faculty of Medicine, Bar-Ilan University, Safed 13115, Israel. · IPATIMUP, University of Porto, Porto 4200-465, Portugal. · Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA. · The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan 52900, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 25605973
  • 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2] Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK [3]. · 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2]. · Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · SAIC-Frederic, National Cancer Institute-Frederick, Frederick, Maryland 21701, USA. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK. · The Methodist Hospital Research Institute, 6670 Bertner Street, Houston, Texas 77030, USA. · Molecular Oncology Department, BC Cancer Agency Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK [3] Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Pubmed 25574598
  • Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Chromatin and Gene Expression Section, Research Triangle Park, Durham, NC, 27709, USA. · Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, 27709, USA. · Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shin Centre, Cambridge, CB2 0RE, UK. · Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Pubmed 25572802
  • 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK [2] Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · 1] Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada [2] Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. · 1] Department of Experimental Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada. · Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada [2] Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [2] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 25470049
  • Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Computer Science, Princeton University, Princeton New Jersey. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Five3 Genomics, Inc., Santa Cruz, California. · Lady Davis Institute for Medical Research, Montreal, Québec, Canada. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation, Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Ahus, Norway. · Pubmed 25351767
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge. · Department of Oncology and Strangeways Research Laboratory, University of Cambridge. Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Pubmed 26133777
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
  • Department of Genetics, Institute for Cancer Research and Department of Pathology, Oslo University Hospital, Oslo, Norway K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 25471453
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · 1] Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia [2] School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire 03755, USA. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, 1066 CX Amsterdam, The Netherlands. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark [3] Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · 1] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium. · 1] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium [2] Vesalius Research Center, University of Leuven, 3000 Leuven, Belgium. · 1] Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Clinical Genetics, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea [3] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea. · Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · 1] Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 94807 Villejuif, France [2] University Paris-Sud, UMRS 1018, 94807 Villejuif, France. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. · 1] Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010 Valencia, Spain [2] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, 33012 Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, 33013 Oviedo, Spain. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Shanghai Center for Disease Control and Prevention, Shanghai 200336, China. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, China. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · 1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8. · 1] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada M5T 3M7 [2] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's &St Thomas' NHS Foundation Trust in partnership with King's College London, London SE1 9RT, UK. · Wellcome Trust Centre for Human Genetics, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Galway, Ireland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia [2] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Singapore Eye Research Institute, National University of Singapore, Singapore 168751, Singapore. · Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, 3075 EA Rotterdam, The Netherlands. · Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria 3010, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] College of Public Health, China Medical University, Taichung 40402, Taiwan, China [2] Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, China. · Department of Surgery, Changhua Christian Hospital, Changhua City 500, Taiwan, China. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway. · 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia. · Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria 3004, Australia. · 1] Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK [2] Institute of Population Health, University of Manchester, Manchester M13 9PL, UK. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK. · Ministry of Public Health, Bangkok 10400, Thailand. · 1] Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Division of General Surgery, National University Health System, Singapore 117597, Singapore. · 1] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore [2] Department of Statistics and Applied Probability, National University of Singapore, Singapore 117546, Singapore. · 1] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA [2] Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Saarland Cancer Registry, 66119 Saarbrücken, Germany. · 1] Division of Breast Cancer Research, Institute of Cancer Research, London SM2 5NG, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · 1] Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada G1V 4G2. · 1] Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1 [2] Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A8. · Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada H3T 1A8. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, NordLab Oulu/Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany [2] University of Tübingen, 72074 Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), 20141 Milan, Italy. · 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy [2] Cogentech Cancer Genetic Test Laboratory, 20133 Milan, Italy. · Department of Obstetrics and Gynaecology, Hannover Medical School, 30625 Hannover, Germany. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, FI-70210 Kuopio, Finland [3] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · Department of Human Genetics &Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, 3075 EA Rotterdam, The Netherlands. · Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens 15310, Greece. · National Cancer Institute, Bangkok 10400, Thailand. · International Agency for Research on Cancer, Lyon, Cedex 08, France. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Bogota, DC 11001000, Colombia. · Department of Epidemiology, University of California Irvine, Irvine, California 92697, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 92697, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Centre d'innovation Génome Québec et Université McGill, Montréal, Quebec, Canada H3A OG1. · McGill University, Montreal, Quebec, Canada H3A OG1. · Cancer Research UK, Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 1L7. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), University of Oslo (UiO), 0450 Oslo, Norway. · 1] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Pubmed 25248036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Five3 Genomics, Santa Cruz, CA 95060, USA. · Stanford Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; San Raffaele University, 20132 Milan, Italy. · Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Thomson Reuters Healthcare & Science, Encinitas, CA 92024, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: · Pubmed 24937458
  • Department of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [3] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · 1] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Institute for Medical Informatics, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · 1] Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] Cambridge Breast Unit, Addenbrooke's Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 24901235
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. · NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Laboratory of Molecular Gerontology, Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224-6825, USA. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24880630
  • K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Cancer Medicine, Surgery and Transplantation, Department of Oncology, Oslo University Hospital, Oslo; · Cancer Research UK, Cambridge Institute; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Department of Pathology and Laboratory Medicine, University of British Colombia; and Molecular Oncology, British Colombia Cancer Research Center, Vancouver, Canada. · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Medicine, Department of Clinical Molecular Oncology, Akershus University Hospital, Lørenskog, Norway; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; · Cancer Research UK, Cambridge Institute; Cambridge Experimental Cancer Medicine Centre; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Pubmed 24803582
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
  • Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Molecular Oncology, British Columbia Cancer Agency, 675 West 10(th) Avenue, V5Z 1L3 Vancouver, Canada. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital, NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cambridge Experimental Cancer Medicine Centre (ECMC), Cambridge CB2 0RE, UK. · Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. Electronic address: · Pubmed 24582497
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Division of Oncology, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24462520
2013
  • Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, United States of America. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Departments of Statistics, Ecology and Evolution, Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois, United States of America. · Pubmed 24349199
  • Cancer Research, UK Cambridge Institute, New Orleans, LA 70124, USA. · Pubmed 23800190
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23380999
2011
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 21944024
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2015
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK (QG, JT, AMD, MS, JEA, DFE, PDPP) · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, SC, AB, FBH) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, SH, DJH, SL) · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, CCh, DJH, SL) · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland (SK, RF, TAM, HN) · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (MKB, QW, JD, KM, ML, SK, DFE, PDPP) · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (JBee, GCT) · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden (KC, HD, ME, JiL, JBr, KH, PH) · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium (DL) · Vesalius Research Center, VIB, Leuven, Belgium (DL) · Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium (CW, KL) · Copenhagen General Population Study, Herlev Hospital, Copenhagen, Denmark (SEB, BGN, SFN) · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Denmark (SEB, BGN, SFN) · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (SEB, BGN) · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Denmark (HF) · Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany (JCC, AR, PS, DC, AHü, RK, MB) · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany (DFJ) · Department of Oncology · Pubmed 25890600
2014
  • Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK. · Pubmed 25472026
  • Authors' Affiliations: Department of Oncology and Strangeways Research Laboratory, University of Cambridge; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; Cambridge Experimental Cancer Medicine Centre, Cambridge; Warwick Clinical Trials Unit, University of Warwick; and Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Pubmed 24599932
2013
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Box 97, Cambridge CB4 3EJ, UK. · Pubmed 23800221
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • Department of Oncology Box 193, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 23299526
  • 1] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] [4]. · Pubmed 24043118
  • Cambridge Breast Unit, Box 97, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 23736032
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23644459
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Pubmed 23635078
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Pubmed 23483540
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 23329232
2012
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, UK. · Pubmed 23047592
  • Hutchison/MRC Research Centre and Department of Pathology, University of Cambridge, Cambridge, UK. · Pubmed 23260012
  • Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK. · Pubmed 22850554
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 22538974
  • Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK. · Pubmed 22522925
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, UK. · Pubmed 22294324
  • Department of Oncology, University of Cambridge, Cambridge, CB1 9RN, UK. · Pubmed 21953021
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, United Kingdom. · Pubmed 21788678
2011
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 22112299
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom. · Pubmed 21527579
  • Cambridge Breast Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK. · Pubmed 21371853
  • Strangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, Wort's Causeway, Cambridge CB1 8RN, UK. · Pubmed 21266980
2010
  • Breast Cancer Functional Genomics Laboratory, Department of Oncology University of Cambridge, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 21050467
  • Department of Oncology, Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Pubmed 20731819
  • Department of Oncology, University of Cambridge, Cambridge CB1 9RN, UK. · Pubmed 20664598
University of London
2019
  • Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: · Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · DCIBERONC, IdISCC Madrid, Spain. · Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy. · Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30771872
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, 94305, CA, USA. · Department of Pathology, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Department of Biology, Stanford University, Stanford, 94305, CA, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Maimonides Medical Center, Brooklyn, 11219, NY, USA. · Norris Comprehensive Cancer Center, Los Angeles, 90033, CA, USA. · Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Cambridge, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. · Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 90333, CA, USA. · Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA. · Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States. · Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA. · Pubmed 30737380
  • Erasmus MC Cancer Institute and Cancer Genomics Netherlands, University Medical Center Rotterdam, Department of Medical Oncology, 3015GD Rotterdam, the Netherlands. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, United Kingdom. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden. · Department of Pathology, Academic Medical Center, 1105AZ Amsterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Département de Biopathologie, Institut Bergonié, CS 61283 33076 Bordeaux, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, B-1000 Brussels, Belgium. · Department of Pathology/TCRU GZA, 2610 Antwerp, Belgium. · Molecular Immunology Unit, Jules Bordet Institute, B-1000 Brussels, Belgium. · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Department of Radiation Oncology, and Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, 6525GA Nijmegen, the Netherlands. · Centre for Clinical Research, Faculty of Medicine, The University of Queensland, 4029 Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, 4029 Brisbane, Australia. · Center for Oncological Research, University of Antwerp, 2610 Antwerp, Belgium. · Istituto Tumori G Paolo II, IRCCS, 70124 Bari, Italy. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands. · Institut Curie, Department of Pathology and INSERM U934, 75248 Paris Cedex 05, France. · Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 38330 Montbonnot-Saint Martin, France. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radiumhospital, 0310 Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, 0310 Oslo, Norway. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands. · Pubmed 30692147
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 30520388
2018
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
  • The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Academic Urology Group, Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Institute of Molecular Biology (IMB), Mainz, Germany. · Department of Biochemistry, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Hinxton, UK. · AstraZeneca, Waltham, MA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · AstraZeneca, Cambridge, UK. · Genome Integrity, Immunity and Cancer Unit, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, Paris, France. · Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan , Amsterdam, the Netherlands. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. · Pubmed 30022119
  • Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. · Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford, CA 94305, USA. · Stanford Cancer Institute, Stanford, CA 94305, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Breast Cancer Program, CRUK Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA; California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA; San Francisco Veterans Affairs Medical Center, San Francisco, San Francisco, CA 94121, USA. · Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. Electronic address: · Pubmed 29731168
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. · The Smoler Protein Center, Department of Biology, Technion, Haifa 32000, Israel. · Cancer Research UK Cambridge Institute and the Cambridge Cancer Centre, Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. · Department of Immunology and Cancer Research and Department Pathology, Hebrew University-Hadassah Medical School, Jerusalem 91010, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 29382783
2017
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Pathology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Computer Science, University of Oslo, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Department of Medicine, University of Oslo, Oslo, Norway. · Department of Oncology, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. Electronic address: · Pubmed 28733194
  • Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. · Department of Oncology, University of Cambridge, and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom. Electronic address: · Pubmed 28694015
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK. · Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Scottish Clinical Trials Research Unit, NHS Natio nal Services Scotland, Edinburgh, UK. · The Christie NHS Foundation Trust, Manchester, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK. · Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK. · Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Exeter Oncology Centre, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. · Department of Oncology, Poole Hospital, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole, Dorset, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Edith Cavell Campus, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK. · Institute of Oncology, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Histopathology, Cambridge, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. · Cancer Clinical Trials Unit (CaCTUS), Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. · Cancer Trials Ireland (formerly ICORG), Dublin, Ireland. · Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. · Department of Surgery and Cancer, Charing Cross Hospital, Imperial College London, London, UK. · Celgene, Research and Development, San Diego, CA, USA. · NIHR/CRUK Christie Clinical Research Facility, Manchester, UK. · Arden Cancer Research Centre, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. · Pubmed 28479233
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Department of Pathology, College of Medicine, Al Mustansiriyah University, Baghdad, Iraq. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Pubmed 28478613
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway. · Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. · Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · Five3 Genomics, LLC, Santa Cruz, CA, 95060, USA. · Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Surgery, Akershus University Hospital, Lørenskog, Norway. · Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. · Department of Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway. · Department of Pathology, Akershus University Hospital, Lørenskog, Norway. · Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Research, Vestre Viken Hospital Trust, Drammen, Norway. · Pubmed 28356166
  • Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK. · Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 27648723
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Pubmed 26776681
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • CIC bioGUNE, Bizkaia Technology Park, Bulding 801a, 48160 Derio, Spain. · Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · Oncology Area, Biodonostia Institute, 20014 San Sebastian, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB-Barcelona), 08028 Barcelona, Spain. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France. · Biodiagnostics Laboratory OncoGenAuvergne, Pathology Unit, Jean Perrin Comprehensive Cancer Center, 63000 Clermont-Ferrand, France. · Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Aix-Marseille University and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 13288 Marseille, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). · IKERBASQUE, Basque foundation for science, 48013 Bilbao, Spain. · Experimental Therapeutics Group, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Weill Cornell Medicine, New York 10021, USA. · Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 10065 New York, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), 48949 Leioa, Spain. · Pubmed 27553708
  • Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. · Cancer Research UK, Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · CCR Collaborative Bioinformatics Resource, Advanced Biomedical Computing Center, Leidos Biomed, Frederick National Laboratory, Frederick, MD, USA. · Breakthrough Breast Cancer Unit, Institute of Cancer Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK. · Pubmed 27181204
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK. · Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK. · Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9. · NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · Pubmed 27161491
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, United Kingdom. · Department of Breast and Endocrine Surgery, Akershus University Hospital, Lorenskog, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Department of Informatics, University of Oslo, Oslo, Norway. · Institute of Cancer Genetics and Informatics, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Pubmed 27082076
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. · Cellular Pathology, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK. · Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE. · Pubmed 26954716
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Pathology, University of Cambridge, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Present address: Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, UK. · Royal Bournemouth Hospital and Bournemouth University, Castle Lane East, Bournemouth, UK. · Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, Peterborough, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Institute of Astronomy, University of Cambridge, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Pubmed 26882907
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
2015
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
  • Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Department of Oncology, Cambridge Cancer Trials Centre, Box 279 (S4), Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. · Level 4, Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, St James Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. · Strangeways Research Laboratory, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Box 193, Cambridge, CB2 0QQ, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Box 277, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · Pubmed 26715442
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. · Center for Noninvasive Diagnostics, Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic Center for Individualized Medicine, Scottsdale, Arizona 85259, USA. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital National Health Service Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0QQ, UK. · Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · BC Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3. · Illumina, Inc., Chesterford Research Park, Little Chesterford CB10 1XL, UK. · Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 26530965
  • Department of Surgery & Cancer, Imperial College London, London, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Statistical Genomics Group, UCL Cancer Institute, University College London, London, UK. · Centre of Mathematics and Physics in Life & Experimental Sciences, University College London, London, UK. · Dundee Cancer Centre, Clinical Research Centre, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. · Pubmed 26280373
  • Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Dame Roma Mitchell Cancer Research Laboratories and the Adelaide Prostate Cancer Research Centre, School of Medicine, Hanson Institute Building, University of Adelaide, Adelaide, South Australia 5005, Australia. · Department of Urology, University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB7295, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [3] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Pubmed 26153859
  • Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK. Electronic address: · Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: · Pubmed 25963740
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Vesalius Research Center (VRC), Vib, Herestraat 49, 3000, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 3M7, Canada. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. · Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, USA. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. · Anatomical Pathology, The Alfred Hospital, Commercial Road, Melbourne, VIC, 3007, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Surgery, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Core Genotyping Facility, Frederick National Laboratory for Cancer Research, 8717 Grovemont Circle, Gaithersburg, MD, 20877, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentena 5, 02-781, Warsaw, Poland. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in Partnership with King's College London, Guy's Campus, SE1 1UL, London, UK. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. · Saarland Cancer Registry, Präsident Baltz Strasse 5, 66119, Saarbrücken, Germany. · School of Medicine, Institute of Clinical Medicine, Oncology and Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. · IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Sydney, NSW 2145, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. · Peter Maccallum Cancer Center, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Sir Peter Maccallum Department of Oncology, University of Melbourne, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández, Almagro, 3, 28029, Madrid, Spain. · Centro de Investigación En Red De Enfermedades Raras (CIBERER), Calle de Álvaro de Bazán, 10 Bajo, 46010, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Frauenklinik der Stadtklinik Baden-Baden, Balger Strasse 50, 76532, Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133, Karlsruhe, Germany. · Department of Oncology - Pathology, Karolinska Institutet, Tomtebodavägen 23b, Stockholm, 171 65, Sweden. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, the University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK. · Early Detection Research Group, Division of Cancer Prevention National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Department of Biology, University of Pisa, Lungarno Pacinotti 43, 56126, Pisa, Italy. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, 715 N Pleasant Street, Amherst, MA, 01002, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. · Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Genetics, Qimr Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. · Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. · Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. · Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 25897948
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. · Pubmed 25897014
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; Department of Computer Science, University College London, London WC1E 6BT, UK; Centre of Mathematics and Physics in the Life Sciences and Experimental Biology, University College London, London WC1E 6BT, UK. · Department of Computer Science, University College London, London WC1E 6BT, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. · Statistical Cancer Genomics, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK; CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai 200031, China. · Pubmed 25793737
  • Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France. · Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France. · Faculté de Médecine, Aix-Marseille Université, Marseille, France. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Pubmed 25669979
  • Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK. · Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Department of Haematology, University of Cambridge, NHS Blood and Transplant, Long Road, Cambridge CB2 0PT, UK [3] Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK [2] Strangeways Research Institute, 2 Worts' Causeway, Cambridge CB1 8RN, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Medical Research Council Toxicology Unit, Lancaster Road, Leicester LE1 9HN, UK. · Pubmed 25611378
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Department of Cell Research and Immunology, George Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. · Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg 69120, Germany. · Kaplan Medical Center, Rehovot 76100, Israel. · Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. · INCPM, Weizmann Institute of Science, Rehovot 76100, Israel. · Faculty of Medicine, Bar-Ilan University, Safed 13115, Israel. · IPATIMUP, University of Porto, Porto 4200-465, Portugal. · Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA. · The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan 52900, Israel. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. · Pubmed 25605973
  • 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2] Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK [3]. · 1] Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK [2]. · Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · SAIC-Frederic, National Cancer Institute-Frederick, Frederick, Maryland 21701, USA. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. · Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK. · The Methodist Hospital Research Institute, 6670 Bertner Street, Houston, Texas 77030, USA. · Molecular Oncology Department, BC Cancer Agency Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK. · 1] Cancer Research UK Cambridge Institute, and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK [3] Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Pubmed 25574598
  • Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Chromatin and Gene Expression Section, Research Triangle Park, Durham, NC, 27709, USA. · Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, 27709, USA. · Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shin Centre, Cambridge, CB2 0RE, UK. · Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. · Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. · Pubmed 25572802
  • 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK [2] Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · 1] Centre for High-Throughput Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada [2] Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. · 1] Department of Experimental Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada. · Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada [2] Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [2] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada. · 1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 25470049
  • Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Computer Science, Princeton University, Princeton New Jersey. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Five3 Genomics, Inc., Santa Cruz, California. · Lady Davis Institute for Medical Research, Montreal, Québec, Canada. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation, Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Ahus, Norway. · Pubmed 25351767
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Oncology, Division for Surgery, Cancer and Transplantation, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Biomedical Informatics Division, Department of Computer Science, University of Oslo, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Norway. · Division of Molecular Pathology, The Institute of Cancer Research, 237 Fulham Road, SW3 6JB, London, UK. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG5 1PB, UK. · King's College London, Breakthrough Breast Cancer Research Unit, London WC2R 2LS, UK; NIHR Comprehensive Biomedical Research Centre at Guy's and St. Thomas NHS Foundation Trust and King's College London, London WC2R 2LS, UK. · Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Manitoba R3E 0V9, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 9RN, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Pathology and Laboratory Medicine, University of British Colombia, Vancouver, British Colombia V6T 2B5, Canada; Molecular Oncology, British Colombia Cancer Research Center, Vancouver, British Columbia V5Z 1L3, Canada. Electronic address: · Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 25169931
  • Department of Oncology and Strangeways Research Laboratory, University of Cambridge. · Department of Oncology and Strangeways Research Laboratory, University of Cambridge. Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. · Pubmed 26133777
2014
  • Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge. · Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham. · University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK. · Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge · Pubmed 24915873
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
  • Department of Genetics, Institute for Cancer Research and Department of Pathology, Oslo University Hospital, Oslo, Norway K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Pubmed 25471453
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · 1] Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia [2] School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire 03755, USA. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, 1066 CX Amsterdam, The Netherlands. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark [3] Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark. · 1] Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Copenhagen, Denmark [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Copenhagen, Denmark. · 1] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium. · 1] Vesalius Research Center (VRC), VIB, 3000 Leuven, Belgium [2] Vesalius Research Center, University of Leuven, 3000 Leuven, Belgium. · 1] Department of Oncology, University of Leuven, 3000 Leuven, Belgium [2] Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Clinical Genetics, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, FI-00029 HUS, Finland. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea [3] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · 1] Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 151-742, Korea. · Department of Surgery, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan. · 1] Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 94807 Villejuif, France [2] University Paris-Sud, UMRS 1018, 94807 Villejuif, France. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany [2] National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. · 1] Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010 Valencia, Spain [2] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, 33012 Oviedo, Spain. · Servicio de Anatomía Patológica, Hospital Monte Naranco, 33013 Oviedo, Spain. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Shanghai Center for Disease Control and Prevention, Shanghai 200336, China. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, China. · CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · 1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8. · 1] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada M5T 3M7 [2] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's &St Thomas' NHS Foundation Trust in partnership with King's College London, London SE1 9RT, UK. · Wellcome Trust Centre for Human Genetics, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Clinical Science Institute, University Hospital Galway, Galway, Ireland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia [2] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500 Selangor, Malaysia. · Singapore Eye Research Institute, National University of Singapore, Singapore 168751, Singapore. · Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, 3075 EA Rotterdam, The Netherlands. · Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria 3010, Australia. · Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] College of Public Health, China Medical University, Taichung 40402, Taiwan, China [2] Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, China. · Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan, China. · Department of Surgery, Changhua Christian Hospital, Changhua City 500, Taiwan, China. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway. · 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia. · Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria 3004, Australia. · 1] Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK [2] Institute of Population Health, University of Manchester, Manchester M13 9PL, UK. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK. · Ministry of Public Health, Bangkok 10400, Thailand. · 1] Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore. · Division of General Surgery, National University Health System, Singapore 117597, Singapore. · 1] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117597, Singapore [2] Department of Statistics and Applied Probability, National University of Singapore, Singapore 117546, Singapore. · 1] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA [2] Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Saarland Cancer Registry, 66119 Saarbrücken, Germany. · 1] Division of Breast Cancer Research, Institute of Cancer Research, London SM2 5NG, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London SM2 5NG, UK. · 1] Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, UK [2] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada G1V 4G2. · 1] Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1 [2] Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A8. · Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada H3T 1A8. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, NordLab Oulu/Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · Department of Oncology, Oulu University Hospital, University of Oulu, FI-90220 Oulu, Finland. · 1] Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany [2] University of Tübingen, 72074 Tübingen, Germany [3] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), 20141 Milan, Italy. · 1] IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy [2] Cogentech Cancer Genetic Test Laboratory, 20133 Milan, Italy. · Department of Obstetrics and Gynaecology, Hannover Medical School, 30625 Hannover, Germany. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, FI-70210 Kuopio, Finland [3] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · 1] Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [2] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, FI-70211 Kuopio, Finland. · Department of Human Genetics &Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, 3075 EA Rotterdam, The Netherlands. · Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens 15310, Greece. · National Cancer Institute, Bangkok 10400, Thailand. · International Agency for Research on Cancer, Lyon, Cedex 08, France. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Bogota, DC 11001000, Colombia. · Department of Epidemiology, University of California Irvine, Irvine, California 92697, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 92697, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Centre d'innovation Génome Québec et Université McGill, Montréal, Quebec, Canada H3A OG1. · McGill University, Montreal, Quebec, Canada H3A OG1. · Cancer Research UK, Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. · 1] The Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada M5T 2M9 [2] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5 [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M5G 1L7. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo (UiO), 0318 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), University of Oslo (UiO), 0450 Oslo, Norway. · 1] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Pubmed 25248036
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Five3 Genomics, Santa Cruz, CA 95060, USA. · Stanford Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; San Raffaele University, 20132 Milan, Italy. · Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai 200092, China. · Thomson Reuters Healthcare & Science, Encinitas, CA 92024, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard School of Public Health, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: · Pubmed 24937458
  • Department of Radiation Biology, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [3] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · Center for Cancer Systems Biology, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. · 1] Department of Pathology, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] Institute for Medical Informatics, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway. · 1] Departments of Genetics, Division of Cancer Medicine, Surgery and Transplantation, Institute for Cancer Research, Oslo University Hospitals - Norwegian Radium Hospital, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, N-0310 Oslo, Norway. · 1] Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] Cambridge Breast Unit, Addenbrooke's Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Pubmed 24901235
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. · NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Laboratory of Molecular Gerontology, Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224-6825, USA. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24880630
  • K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Cancer Medicine, Surgery and Transplantation, Department of Oncology, Oslo University Hospital, Oslo; · Cancer Research UK, Cambridge Institute; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Department of Pathology and Laboratory Medicine, University of British Colombia; and Molecular Oncology, British Colombia Cancer Research Center, Vancouver, Canada. · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Medicine, Department of Clinical Molecular Oncology, Akershus University Hospital, Lørenskog, Norway; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; · Cancer Research UK, Cambridge Institute; Cambridge Experimental Cancer Medicine Centre; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Pubmed 24803582
  • Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium. · Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain. · University Hospital of Heraklion, Heraklion, Greece. · Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy. · AZ Istituti Ospitalieri di Cremona, Cremona, Italy. · Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain. · Imperial College and Imperial College Healthcare NHS Trust, London, UK. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · Hospital 12 de Octubre, Madrid, Spain. · IOV-IRCCS, Padova, Italy. · Hospital de Navarra, Pamplona, Spain. · Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium; Department of Oncology, KU-Leuven, Leuven, Belgium. · Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Frauenklinik, University of Ulm, Ulm, Germany. · Clinical oncology, Hospital Arnau de Vilanova, Valencia, Spain. · Saarland University, Homburg, Germany. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Medical Oncology and SIRIC, Institut Curie, Paris, France; Université Paris Descartes, Paris, France. Electronic address: · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 24636208
  • Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 08907, Spain. · Department of Molecular Oncology, British Columbia Cancer Agency, 675 West 10(th) Avenue, V5Z 1L3 Vancouver, Canada. · Department of Oncology and Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital, NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cambridge Experimental Cancer Medicine Centre (ECMC), Cambridge CB2 0RE, UK. · Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. Electronic address: · Pubmed 24582497
  • Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK; Division of Oncology, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. Electronic address: · Pubmed 24462520
2013
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23380999
2011
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 21944024
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2014
  • Authors' Affiliations: Department of Oncology and Strangeways Research Laboratory, University of Cambridge; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; Cambridge Experimental Cancer Medicine Centre, Cambridge; Warwick Clinical Trials Unit, University of Warwick; and Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Pubmed 24599932
2013
  • Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23395906
  • 1] Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK [2] Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [3] [4]. · Pubmed 24043118
  • Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23644459
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. · Pubmed 23635078
  • Cancer Research UK Cambridge Institute and University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23563269
  • Department of Oncology, University of Cambridge and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Pubmed 23484797
2012
  • Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK. · Pubmed 23100629
  • Cancer Research UK, Cambridge Research Institute and Department of Oncology, University of Cambridge, UK. · Pubmed 22294324
2010
  • Breast Cancer Functional Genomics Laboratory, Department of Oncology University of Cambridge, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 21050467
Miscellaneous institutions in Cambridge, UK
2018
  • Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom. · Department of Life Sciences, Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. · Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 30507376
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Regenerative Medicine Center, University Medical Center Utrecht Uppsalalaan 6, Utrecht, The Netherlands. · Mechanisms of Transcription Laboratory, The Francis Crick Institute, London NW1 1AT, UK. · Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, The Netherlands. · Division of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, 3484 EA Utrecht, The Netherlands. · Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK. · Pubmed 30137431
2017
  • Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK. · Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK. · Department of Biology, University of Pisa, Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Saarland Cancer Registry, Saarbrücken, Germany. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · VIB Center for Cancer Biology, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center - Oncology Institute, Warsaw, Poland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Anatomical Pathology, The Alfred Hospital, Melbourne, Australia. · Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. · Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia. · Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA. · Department of Pathology, The University of Melbourne, Melbourne, Australia. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. · Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 29232439
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK. · Pathology Department, Faculty of Medicine, Menoufyia University, Menoufyia 110532, Egypt. · Cancer Research UK, Cambridge Research Institute, Cambridge CB 0RE, UK. · Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il 2440, Saudi Arabia. · Department of Biology, Georgia State University, Atlanta, GA 30303, USA. · Pubmed 28829761
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts, USA. · Harvard Medical School, Boston, Massachusetts, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Bioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia. · Department of Radiation Oncology, Brigham &Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biology, MIT, Cambridge, Massachusetts, USA. · Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA. · Departments of Medical Oncology, Pathology, and Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Research UK Cambridge Centre, Cambridge, UK. · Department of Oncology, University of Cambridge Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK. · Van Andel Research Institute, Grand Rapids, Michigan, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts, USA. · Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Bethesda, Maryland, USA. · Department of Human Genetics, Lady Davis Institute for Medical Research and Research Institute McGill University Health Centre, McGill University, Montreal, Quebec, Canada. · Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Pubmed 28825726
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy & Developmental Biology, Monash University, Clayton, VIC, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Research and Development, Lincoln Breast Unit, Lincoln County Hospital, Lincoln, UK. · Nottingham Digestive Disease Centre, Faculty of Medicine and Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK. · PathLinks, Lincoln County Hospital, Lincoln, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 28697743
  • 1 MRC Biostatistics Unit, Cambridge, UK. · 2 Cancer Research UK Cambridge Institute, Cambridge, UK. · 3 Department of Pathology, University of Cambridge, Cambridge, UK. · 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · 5 Department of Oncology, University of Cambridge, Cambridge, UK. · 6 NIH Cambridge Biomedical Research Centre, Cambridge, UK. · 7 Strangeways Research Laboratory, Cambridge, UK. · Pubmed 25193065
2016
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom. · Breast Cancer Programme, Cambridge Cancer Centre, Cambridge CB2 2QQ, United Kingdom. · Pubmed 28381438
  • Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Department of Electron Microscopy/Molecular Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom. · Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, United Kingdom. · Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. · Leeds Institute of Cancer and Pathology and Leeds Experimental Cancer Medical Centre, Leeds, United Kingdom. · Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. · Pubmed 27392074
  • Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. · John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK. · Liggins Institute, University of Auckland, Auckland, New Zealand; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Liggins Institute, University of Auckland, Auckland, New Zealand. · Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK. · Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: · Pubmed 27312051
  • Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. · Department of Molecular Cell Biology, Leiden University Medical Center, Einthovenweg 20, 2300 RC Leiden, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA. · Pubmed 28004812
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, 3800, Australia. · School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB1 9RN, UK. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK. · Pubmed 27542606
  • Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK. · Department of Pathology, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt. · Department of Oncology, Azadi Teaching Hospital, Duhok, Kurdistan, 1014 AM, Iraq. · Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il, Saudi Arabia. · Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK. · Department of Surgery and Cancer, Imperial College London, London, UK. · Centre for the Cambridge Experimental Cancer Medicine Centre (ECMC) and Cambridge Breast Cancer Research Unit, Cambridge, UK. · Department of Pathology, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt. · Pubmed 27514395
  • Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. · Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA. · Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA. · Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA. · MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK. · GlaxoSmithKline, Collegeville, PA, 19425, USA. · Cytokinetics, Inc., South San Francisco, CA, 94080, USA. · Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada. · Cancer Research UK, Cambridge Institute, Cambridge, UK. · Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. · Pubmed 27368372
2015
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK. · Academic Haematology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK. · Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham NG51PB, UK; Department of Oncology, Nottingham University Hospitals, Nottingham NG51PB, UK. Electronic address: · Pubmed 25205036
  • Dame Roma Mitchell Cancer Research Laboratories, Discipline of Medicine, The University of Adelaide, SA 5005, Australia. · Computational Biology Program, Public Health Sciences Division, Seattle, WA 98109, USA. · Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Bedford Park, SA 5042, Australia. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55905, USA. · Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55905, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, SA 5005, Australia. · Pubmed 26554309
  • Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. · Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. · Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · MTA TTK Lendület Cancer Biomarker Research Group, Second Department of Pediatrics, Semmelweis University and MTA-SE Pediatrics and Nephrology Research Group, Budapest 1085, Hungary. · MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. · Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. Electronic address: · Pubmed 26411678
  • Department of Oncology, University of Cambridge, Cambridge, UK ; Department of Gynecology and Obstetrics, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil. · Department of Physics (Astrophysics), University of Oxford, Oxford, UK. · Cancer Research UK, Cambridge Institute, Cambridge, UK. · University of Southampton, Southampton, UK. · University of Leeds, Leeds, UK. · Addenbrookes Hospital NHS Trust, Cambridge, UK. · Institute of Cancer Research, London, UK. · Cancer Research UK, London, UK. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Oncology, University of Cambridge, Cambridge, UK ; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain ; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia ; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Finland. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Oncology, University of Cambridge, Cambridge, UK. · National Cancer Institute, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany ; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany ; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarbrücken, Germany. · Pubmed 26288840
  • Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada5Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada. · Expression Regulation in Cancer Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal. · Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada. · Division of Anatomical Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada. · The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada9Rosalind and Morris Goodman Cancer Research Centre, Montreal, Quebec, Canada. · Human Reproduction Service, University Hospitals of Coimbra, Coimbra, Portugal11Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Lisbon Portugal. · Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada. · Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Frauenshuh Cancer Center, Park Nicollet Clinic, St Louis Park, Minnesota. · Cancer Research UK Cambridge Institute, Cambridge, England. · Provincial Medical Genetics Program, St John's, Newfoundland, Canada. · Department of Health Science Research, Mayo Clinic, Scottsdale, Arizona. · Cancer Care Program, Dr. H. Bliss Murphy Cancer Centre Eastern Health, St John's, Newfoundland, Canada. · Institute of Pathology, Technische Universität München, München, Germany. · Creighton's Hereditary Cancer Center, Omaha, Nebraska. · Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada22Samuel Lunenfeld Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada. · Department of Experimental Oncology, European Institute of Oncology, Milano, Italy24Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy. · Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy25Istituto Toscano Tumori (ITT), University Hospital of Siena, Siena, Italy. · Expression Regulation in Cancer Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal26Faculty of Medicine, University of Porto, Porto, Portugal. · Department of Oncology, University of Cambridge, Strangeway's Research Laboratory, Wort's Causeway, Cambridge, England28Department of Public Health and Primary Care, University of Cambridge, Strangeway's Research Laboratory, Wort's Causeway, Cambridge, En. · Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular. · Pubmed 26182300
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Cancer Research UK Cambridge Research Institute Li Ka Shing Centre, Cambridge, UK. · Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel. · Chemical Physics, Weizmann Institute of Science, Rehovot, Israel. · Division of Molecular Genome Analysis, German Cancer Research Centre (DKFZ), Heidelberg, Germany. · Biological Services, Weizmann Institute of Science, Rehovot, Israel. · IPATIMUP - Institute of Molecular Pathology and Immunology, Medical Faculty of the University of Porto, Porto, Portugal. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel · Pubmed 25678558
2016
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. · Department of Pathology, University of Cambridge, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom. · CRUK & EPSRC Cancer Imaging Centre in Cambridge and Manchester, Cambridge, United Kingdom. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Pubmed 27959923
2013
  • Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Pubmed 23412800
  • Cambridge Research Institute, Cancer Research UK, Cambridge, United Kingdom. · Pubmed 24069272
  • Cancer Research UK, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23871723
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 23403292
2012
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK. · Pubmed 22968701
  • Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Pubmed 22217937
2011
  • Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge, UK. · Pubmed 22128823
  • Cancer Research UK, Cambridge Research Institute, Cambridge, UK. · Pubmed 21337521
Unspecified
2017
  • Li Ka Shing Centre, Cancer Research UK Cambridge Institute. · Department of Pathology. · Institute of Astronomy, University of Cambridge, Cambridge. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge. · Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Canada. · Pubmed 28525534
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
2014
  • Affiliations of authors: MRC Cancer Unit, Cambridge, UK (C-AJO, CSR-I, MO, CEW, AN, RCF) · Cancer Research UK Cambridge Institute, Cambridge, UK (NBS, OMR, D-eH, MIK, CC, KB) · UK Cambridge Esophagogastric Centre, Addenbrooke's Hospital, Cambridge, UK (RHH). · Pubmed 24777112
2015
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK (QG, JT, AMD, MS, JEA, DFE, PDPP) · Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands (MKS, SC, AB, FBH) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, SH, DJH, SL) · Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, MA (PK, CCh, DJH, SL) · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland (SK, RF, TAM, HN) · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (MKB, QW, JD, KM, ML, SK, DFE, PDPP) · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia (JBee, GCT) · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden (KC, HD, ME, JiL, JBr, KH, PH) · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium (DL) · Vesalius Research Center, VIB, Leuven, Belgium (DL) · Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium (CW, KL) · Copenhagen General Population Study, Herlev Hospital, Copenhagen, Denmark (SEB, BGN, SFN) · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Denmark (SEB, BGN, SFN) · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (SEB, BGN) · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Denmark (HF) · Division of Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany (JCC, AR, PS, DC, AHü, RK, MB) · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany (DFJ) · Department of Oncology · Pubmed 25890600
University of Oslo
2014
  • K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Cancer Medicine, Surgery and Transplantation, Department of Oncology, Oslo University Hospital, Oslo; · Cancer Research UK, Cambridge Institute; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Department of Pathology and Laboratory Medicine, University of British Colombia; and Molecular Oncology, British Colombia Cancer Research Center, Vancouver, Canada. · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; Division of Medicine, Department of Clinical Molecular Oncology, Akershus University Hospital, Lørenskog, Norway; · Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine; · Cancer Research UK, Cambridge Institute; Cambridge Experimental Cancer Medicine Centre; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; · Pubmed 24803582
24 Other Locations Show
Yearly article counts 581619291622161060
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.